Belgium-Luxembourg (...1998) products
Belgium-Luxembourg (...1998): Pharmaceutical products
HS chapter 30 · Chemicals
Pharmaceutical products
Belgium-Luxembourg (...1998) pharmaceutical products over time
US$, annual.
In more detail
| Heading | Value | Share |
|---|---|---|
| 3002 Human blood | US$28.4 billion | 54.4% |
| 3004 Medicaments | US$22.2 billion | 42.4% |
| 3006 Pharmaceutical goods | US$827.8 million | 1.6% |
| 3003 Medicaments | US$529.7 million | 1.0% |
| 3005 Wadding, gauze, bandages (dressings, adhesive plasters… | US$255.5 million | 0.5% |
| 3001 Glands and other organs (extracts, secretions thereof)… | US$28.7 million | 0.1% |
| Product | Value | Share |
|---|---|---|
| 300490 Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | US$19.3 billion | 36.9% |
| 300290 Toxins, cultures of micro-organisms (excluding yeasts) and similar products | US$13.9 billion | 26.6% |
| 300220 Vaccines: for human medicine | US$13.7 billion | 26.2% |
| 300439 Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | US$1.3 billion | 2.5% |
| 300210 Blood: human and animal, antisera and other blood fractions | US$691.3 million | 1.3% |
| 300420 Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | US$655.4 million | 1.3% |
| 300432 Medicaments: containing adrenal cortex hormones (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | US$637.0 million | 1.2% |
| 300390 Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | US$428.5 million | 0.8% |
| 300610 Pharmaceutical goods: sterile surgical catgut, suture materials, tissue adhesives, laminaria, laminaria tents and absorbable surgical or dental haemostatics | US$394.8 million | 0.8% |
| 300630 Pharmaceutical goods: opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | US$218.0 million | 0.4% |
| Heading | Value | Share |
|---|---|---|
| 3004 Medicaments | US$22.4 billion | 50.3% |
| 3002 Human blood | US$17.0 billion | 38.4% |
| 3003 Medicaments | US$3.3 billion | 7.5% |
| 3006 Pharmaceutical goods | US$1.3 billion | 2.9% |
| 3005 Wadding, gauze, bandages (dressings, adhesive plasters… | US$229.5 million | 0.5% |
| 3001 Glands and other organs (extracts, secretions thereof)… | US$171.2 million | 0.4% |
| Product | Value | Share |
|---|---|---|
| 300490 Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | US$19.4 billion | 43.6% |
| 300290 Toxins, cultures of micro-organisms (excluding yeasts) and similar products | US$10.5 billion | 23.7% |
| 300220 Vaccines: for human medicine | US$6.0 billion | 13.5% |
| 300339 Medicaments: containing hormones (excluding insulin), (but not containing antibiotics), for therapeutic or prophylactic uses, not packaged for retail sale | US$2.3 billion | 5.2% |
| 300439 Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | US$1.6 billion | 3.7% |
| 300390 Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | US$990.8 million | 2.2% |
| 300610 Pharmaceutical goods: sterile surgical catgut, suture materials, tissue adhesives, laminaria, laminaria tents and absorbable surgical or dental haemostatics | US$917.5 million | 2.1% |
| 300420 Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | US$800.5 million | 1.8% |
| 300210 Blood: human and animal, antisera and other blood fractions | US$439.5 million | 1.0% |
| 300432 Medicaments: containing adrenal cortex hormones (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | US$193.7 million | 0.4% |
Shares are of Belgium-Luxembourg (...1998)'s pharmaceutical products in the same direction. See Pharmaceutical products for all countries or all of Belgium-Luxembourg (...1998)'s trade.
More Belgium-Luxembourg (...1998) products
- 27 Mineral fuels, mineral oils and products of their distillation
- 87 Vehicles
- 84 Machinery and mechanical appliances, boilers, nuclear reactors
- 39 Plastics and articles thereof
- 85 Electrical machinery and equipment and parts thereof
- 29 Organic chemicals
- 71 Natural, cultured pearls
- 72 Iron and steel
- 90 Optical, photographic, cinematographic, measuring, checking, medical or surgical instruments and apparatus
- 38 Chemical products n.e.c.
- 20 Preparations of vegetables, fruit, nuts or other parts of plants
- 18 Cocoa and cocoa preparations
Belgium-Luxembourg (...1998) pharmaceutical products: questions and answers
How much pharmaceutical products does Belgium-Luxembourg (...1998) export?
In 2024, Belgium-Luxembourg (...1998) exported US$52.2 billion of pharmaceutical products (HS chapter 30), 13.5% of its total exports. That ranks it 7 of 213 exporting countries in the data.
What are Belgium-Luxembourg (...1998)'s biggest pharmaceutical products exports?
In 2024, the largest 4-digit headings were Human blood (3002, US$28.4 billion), Medicaments (3004, US$22.2 billion), Pharmaceutical goods (3006, US$827.8 million).
How much pharmaceutical products does Belgium-Luxembourg (...1998) import?
In 2024, Belgium-Luxembourg (...1998) imported US$44.4 billion of pharmaceutical products (HS chapter 30), 11.4% of its total imports. That ranks it 5 of 226 importing countries in the data.
What are Belgium-Luxembourg (...1998)'s biggest pharmaceutical products imports?
In 2024, the largest 4-digit headings were Medicaments (3004, US$22.4 billion), Human blood (3002, US$17.0 billion), Medicaments (3003, US$3.3 billion).
